ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bullish•Celltrion Inc
•01 Apr 2020 20:13

Block Deal Sales of Celltrion & Celltrion Healthcare Stakes by ION Investments

It was reported after the market close today that GIC's investment affiliate ION Investments has put up its shares in Celltrion Inc (068270 KS) and...

Logo
514 Views
Share
bearish•Celltrion Inc
•01 Apr 2020 17:32

Celltrion+Celltrion Healthcare Placement- Discount Looks Enticing but the Deal Appears Opportunistic

Temasek plans to raise US$380m via selling 1.9% stake in Celltrion Healthcare (091990 KS) and another US$132m via selling a 1.5% stake in Celltrion...

Logo
486 Views
Share
bearish•Celltrion Healthcare
•31 Mar 2020 13:10

Celltrion Merger: Potential Controversy from Healthcare's Inventory Situation

Celltrion held the annual general meeting on March 27. During this meeting, CEO Seo reaffirmed the merger between the three siblings. He...

Logo
504 Views
Share
bearish•Celltrion Healthcare
•29 Mar 2020 10:02

Short Sell Ban in Korea: Targeting Block Deal Sell Swap Traders?

Korea's short-selling ban began on March 16. It will be in place for six months until September 15. Of course, market makers and program trading...

Logo
403 Views
Share
bearish•MSCI ACWI Index
•27 Mar 2020 09:25

Global Equity Strategy: Initial Low Established

Several equity indexes and indicators we watch are telling us an initial primary low has been established for global equities (ACWI-US). At the...

Logo
566 Views
Share
x